Scienture (SCNX) Competitors $2.39 +0.32 (+15.46%) Closing price 08/6/2025 04:00 PM EasternExtended Trading$2.36 -0.03 (-1.26%) As of 08/6/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock SCNX vs. DLXY, UFG, WGRX, GDC, NHTC, RAVE, TLIH, LTCH, DTCK, and CGTLShould you be buying Scienture stock or one of its competitors? The main competitors of Scienture include Delixy (DLXY), Uni-Fuels (UFG), Wellgistics Health (WGRX), GD Culture Group (GDC), Natural Health Trends (NHTC), Rave Restaurant Group (RAVE), Ten-League International (TLIH), Latch (LTCH), Davis Commodities (DTCK), and Creative Global Technology (CGTL). These companies are all part of the "wholesale" industry. Scienture vs. Its Competitors Delixy Uni-Fuels Wellgistics Health GD Culture Group Natural Health Trends Rave Restaurant Group Ten-League International Latch Davis Commodities Creative Global Technology Delixy (NASDAQ:DLXY) and Scienture (NASDAQ:SCNX) are both small-cap wholesale companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability. Is DLXY or SCNX more profitable? Delixy has a net margin of 0.00% compared to Scienture's net margin of -10,364.22%. Delixy's return on equity of 0.00% beat Scienture's return on equity.Company Net Margins Return on Equity Return on Assets DelixyN/A N/A N/A Scienture -10,364.22%-22.57%-18.12% Which has better earnings and valuation, DLXY or SCNX? Scienture has lower revenue, but higher earnings than Delixy. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelixy$314.92M0.25N/AN/AN/AScienture$146.90K262.44$9.07MN/AN/A Does the media prefer DLXY or SCNX? In the previous week, Delixy had 1 more articles in the media than Scienture. MarketBeat recorded 1 mentions for Delixy and 0 mentions for Scienture. Delixy's average media sentiment score of 0.00 equaled Scienture'saverage media sentiment score. Company Overall Sentiment Delixy Neutral Scienture Neutral Do institutionals & insiders have more ownership in DLXY or SCNX? 5.7% of Scienture shares are held by institutional investors. 49.7% of Scienture shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. SummaryDelixy beats Scienture on 5 of the 8 factors compared between the two stocks. Get Scienture News Delivered to You Automatically Sign up to receive the latest news and ratings for SCNX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SCNX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCNX vs. The Competition Export to ExcelMetricScientureMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$33.39M$2.52B$5.57B$9.47BDividend YieldN/A1.78%4.31%4.13%P/E RatioN/A19.5129.3723.99Price / Sales262.44691.00444.1896.63Price / CashN/A162.3535.8458.51Price / Book0.265.208.085.58Net Income$9.07M$31.61M$3.26B$265.35M7 Day Performance23.20%0.90%0.45%-0.07%1 Month Performance47.53%6.97%4.83%1.76%1 Year PerformanceN/A6.15%30.28%25.39% Scienture Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCNXScientureN/A$2.39+15.5%N/AN/A$33.39M$146.90K0.00N/AUpcoming EarningsDLXYDelixyN/A$4.98+1.4%N/AN/A$80.36MN/A0.00N/AGap UpUFGUni-FuelsN/A$2.76+3.4%N/AN/A$80.10M$155.19M0.0017Gap DownHigh Trading VolumeWGRXWellgistics HealthN/A$0.88-11.2%N/AN/A$74.96M$18.13M0.0031GDCGD Culture Group0.9306 of 5 stars$3.28+1.2%N/A+125.2%$54.42MN/A-3.1860News CoverageUpcoming EarningsNHTCNatural Health Trends1.4803 of 5 stars$4.64-0.6%N/A-30.6%$53.79M$42.96M92.82140RAVERave Restaurant Group0.6765 of 5 stars$2.95+2.4%N/A+56.5%$40.93M$12.15M15.5320Gap DownTLIHTen-League InternationalN/A$0.80-19.2%N/AN/A$29.11MN/A0.0064LTCHLatchN/A$0.14-6.7%N/A-65.7%$23.08M$48.39M0.00420Gap DownHigh Trading VolumeDTCKDavis Commodities0.8817 of 5 stars$0.90+0.7%N/A-18.5%$21.91M$132.37M0.0022Gap DownCGTLCreative Global TechnologyN/A$0.95-3.5%N/AN/A$21.10M$35.61M0.00N/AGap Down Related Companies and Tools Related Companies DLXY Competitors UFG Competitors WGRX Competitors GDC Competitors NHTC Competitors RAVE Competitors TLIH Competitors LTCH Competitors DTCK Competitors CGTL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SCNX) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scienture Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Scienture With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
